COVID-19
Drug-interactions
Gene-analysis
Interaction networks
Pathways
Journal
Saudi journal of biological sciences
ISSN: 1319-562X
Titre abrégé: Saudi J Biol Sci
Pays: Saudi Arabia
ID NLM: 101543796
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
10
12
2020
revised:
31
12
2020
accepted:
06
01
2021
pubmed:
2
2
2021
medline:
2
2
2021
entrez:
1
2
2021
Statut:
ppublish
Résumé
Researchers worldwide with great endeavor searching and repurpose drugs might be potentially useful in fighting newly emerged coronavirus. These drugs show inhibition but also show side effects and complications too. On December 27, 2020, 80,926,235 cases have been reported worldwide. Specifically, in Pakistan, 471,335 has been reported with inconsiderable deaths. Identification of COVID-19 drugs pathway through drug-gene and gene-gene interaction to find out the most important genes involved in the pathway to deal with the actual cause of side effects beyond the beneficent effects of the drugs. The medicines used to treat COVID-19 are retrieved from the Drug Bank. The drug-gene interaction was performed using the Drug Gene Interaction Database to check the relation between the genes and the drugs. The networks of genes are developed by Gene MANIA, while Cytoscape is used to check the active functional association of the targeted gene. The developed systems cross-validated using the EnrichNet tool and identify drug genes' concerned pathways using Reactome and STRING. Five drugs Azithromycin, Bevacizumab, CQ, HCQ, and Lopinavir, are retrieved. The drug-gene interaction shows several genes that are targeted by the drug. Gene MANIA interaction network shows the functional association of the genes like co-expression, physical interaction, predicted, genetic interaction, co-localization, and shared protein domains. Our study suggests the pathways for each drug in which targeted genes and medicines play a crucial role, which will help experts
Identifiants
pubmed: 33519272
doi: 10.1016/j.sjbs.2021.01.006
pii: S1319-562X(21)00006-1
pmc: PMC7825994
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2029-2039Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W115-22
pubmed: 23794635
Aust Prescr. 2015 Jun;38(3):87-9
pubmed: 26648627
J Infect. 2020 Jul;81(1):e21-e23
pubmed: 32283143
Thorax. 2004 Mar;59(3):252-6
pubmed: 14985565
PLoS One. 2014 Oct 01;9(10):e109180
pubmed: 25271834
N Engl J Med. 2020 Oct 29;383(18):1757-1766
pubmed: 32329974
J Microbiol Immunol Infect. 2020 Jun;53(3):436-443
pubmed: 32307245
Pharmacogenet Genomics. 2017 Apr;27(4):164-167
pubmed: 28146011
Oncotarget. 2017 Feb 14;8(7):12389-12405
pubmed: 27852039
Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6
pubmed: 18048412
Expert Opin Drug Saf. 2017 Mar;16(3):411-419
pubmed: 27927040
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
BMC Bioinformatics. 2019 Dec 30;20(1):740
pubmed: 31888434
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Pharmacol Ther. 2018 Feb;182:152-160
pubmed: 28882537
Drug Saf. 2018 Oct;41(10):919-931
pubmed: 29858838
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Drug Discov Ther. 2020;14(1):58-60
pubmed: 32147628
Can J Cardiol. 2014 Dec;30(12):1706-15
pubmed: 25475472
Bioinformatics. 2010 Nov 15;26(22):2927-8
pubmed: 20926419
Bioinformatics. 2012 Sep 15;28(18):i451-i457
pubmed: 22962466
Clin Cancer Res. 2008 Sep 15;14(18):5893-9
pubmed: 18794102
Nucleic Acids Res. 2014 Jan;42(Database issue):D1091-7
pubmed: 24203711
Trials. 2018 Jan 30;19(1):81
pubmed: 29382391
Nucleic Acids Res. 2018 Jan 4;46(D1):D1068-D1073
pubmed: 29156001
Nucleic Acids Res. 2018 Jul 2;46(W1):W60-W64
pubmed: 29912392
Bioinformatics. 2015 Feb 1;31(3):306-10
pubmed: 25316676
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
J Transl Med. 2019 Nov 8;17(1):362
pubmed: 31703698
Genome Biol. 2019 Sep 2;20(1):185
pubmed: 31477170
Nat Methods. 2013 Dec;10(12):1209-10
pubmed: 24122041
Drug Saf. 2020 May;43(5):393-394
pubmed: 32266694
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W214-20
pubmed: 20576703
BMC Bioinformatics. 2017 Mar 2;18(1):142
pubmed: 28249561
Am J Med. 1991 Sep 12;91(3A):40S-45S
pubmed: 1656742
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nat Rev Rheumatol. 2018 Dec;14(12):693-703
pubmed: 30401979
J Biomol Struct Dyn. 2021 May;39(8):2904-2913
pubmed: 32306822
NPJ Genom Med. 2020 Aug 18;5:35
pubmed: 32864162
Ann Otol Rhinol Laryngol. 2019 May;128(5):467-471
pubmed: 30693788
Cancer Treat Rev. 2020 Jun;86:102017
pubmed: 32335505
Ther Deliv. 2020 Apr;11(4):245-268
pubmed: 32397911
J Biomol Struct Dyn. 2021 Apr;39(7):2607-2616
pubmed: 32238094
Nat Med. 2020 Apr;26(4):465
pubmed: 32273604
BMJ. 2020 Apr 8;369:m1432
pubmed: 32269046
Expert Rev Anti Infect Ther. 2021 Jan;19(1):5-16
pubmed: 32693652
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
Genome Biol. 2008;9 Suppl 1:S4
pubmed: 18613948